Journals / Türkiye Parazitoloji Dergisi / 2017 / Cilt: 41 - Sayı: 3

Chronic Hepatitis B and Leishmania Coinfection

Kronik Hepatit B-Leishmania Koinfeksiyonu

Pages
177–179
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Visceral leishmaniasis should be considered as an infectious disease in the differential diagnosis of chronic liver diseases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Visceral leishmaniasis is an endemic disease in many parts of world, and if untreated, it is a potentially life-threatening infectious disease.
📊
Key Findings & Data:It is similar to chronic liver disease because of signs and symptoms such as fever, weight loss, hepatosplenomegaly, and pancytopenia.
💡
Conclusion & Impact:Visceral leishmaniasis should be considered as an infectious disease in the differential diagnosis of chronic liver diseases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Visceral leishmaniasis is an endemic disease in many parts of world, and if untreated, it is a potentially life-threatening infectious disease. It is similar to chronic liver disease because of signs and symptoms such as fever, weight loss, hepatosplenomegaly, and pancytopenia. In this study, we present a case of visceral leishmaniasis, which is known to be a chronic hepatitis B infection, that was coincidentally diagnosed with liver biopsy. Visceral leishmaniasis should be considered as an infectious disease in the differential diagnosis of chronic liver diseases.

Özet

Visseral leishmaniasis, dünyanın pek çok bölgesinde endemik olarak görülen, tedavi edilmediği takdirde yaşamı tehdit eden bir enfeksiyonhastalığıdır. Ateş, kilo kaybı, hepatosplenomegali, pansitopeni gibi semptom ve bulgular nedeniyle kronik karaciğer hastalıkları ile benzerlikgöstermektedir. Bu çalışmada kronik hepatit B enfeksiyonu olduğu bilinen, karaciğer biyopsisi ile rastlantısal olarak tanı konulan bir visseralleishmaniasis olgusu sunulmuştur. Visseral leishmaniasis, bir enfeksiyon hastalığı olarak kronik karaciğer hastalıklarının ayırıcı tanısında dikkatealınmalıdır.

🔖

Cite This Article

DEMİRDAL, T., NEMLİ, S. A., SARI, Ü. S., EL, S., URAL, S. (2022). Chronic Hepatitis B and Leishmania Coinfection. Türkiye Parazitoloji Dergisi, Cilt: 41 - Sayı: 3, 177–179. https://ajindex.com/articles/630117

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Magill AJ. Leishmania Species: Visceral (Kala-Azar), Cutaneous, and Mucosal Leishmaniasis. Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Eight edition. Philadelphia: Churchill Livingstone; 2015. p. 3091-107. WHO: Programmes: Leishmaniasis http://www.who.int/leishmaniasis/en/ (erişim tarihi: 29.04.16) Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-51. [CrossRef] Güleç SG, Kizilyer Y, Karaman S, Erdem E, Urganci N. Case report: the efficacy of amphotericin B in visceral leishmaniasis. Turkiye Parazitol Derg 2010; 34: 73-5.
  2. Kurşun E, Turunç T, Demiroğlu YZ, Solmaz S, Arslan H. Evaluation of fourteen adult cases with visceral leishmaniasis. Mikrobiyol Bul 2013; 47: 500-6. [CrossRef] Bayan K, Tuzun Y, Gullu N, Yılmaz S. From Preceding Diagnosis of Complicated Liver Cirrhosis to Kala-Azar in a Patient with Chronic Hepatitis B: Case Report. Turkiye Klinikleri J Gastroenterohepatol 2009; 16: 27-9.
  3. Ozensoy S, Ozbel Y, Turgay N, Alkan MZ, Gul K, Gilman-Sachs A, et al. Serodiagnosis and epidemiology of visceral leishmaniasis in Turkey. Am J Trop Med Hyg 1998; 59: 363-9. [CrossRef] Van Griensven J, Carrillo E, López-Vélez R, Lynen L, Moreno J. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect 2014; 20: 286-99. [CrossRef] Ozkan AT, Yalçinkaya T, Kiliç S, Babür C, Schallig HD. Investigation of Leishmania infantum seropositivity in HIV/AIDS patients. Mikrobiyol Bul 2008; 42: 113-7.
  4. Zümrütdal A, Erken E, Turunç T, Çolakoğlu Ş, Demıroğlu YZ, Özelsancak R, et al. Delayed and overlooked diagnosis of an unusual opportunistic infection in a renal transplant recipient: visceral leishmaniasis. Turkiye Parazitol Derg 2010; 34: 183-5. [CrossRef] Prakash A, Singh NP, Sridhara G, Malhotra V, Makhija A, Garg D, et al. Visceral Leishmaniasis masquerading as chronic liver disease. J Assoc Phys India 2006; 54: 893-4.
  5. Giannitrapani L, Soresi M, La Spada E, Tripodo C, Montalto G. Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report. J Med Case Rep 2009; 25: 7265. [CrossRef] Sakkas H, Gartzonika C, Levidiotou S. Laboratory diagnosis of human visceral leishmaniasis. J Vector Borne Dis 2016; 53: 8-16.
  6. Singh OP, Singh B, Chakravarty J, Sundar S. Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective. Infect Dis Poverty 2016; 5: 19. [CrossRef] Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M,